Aaron G.L. Fletcher sold $168k of LTRN
owner at Lantern Pharma Inc.. 56,237 shares at an average of $2.99, traded May 27, 2025, filed May 29, 2025.
Score components
- +12Role10% owner
- +11Trade size$168k at market
- +10Share of holdings soldSold 26% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +1.9%, 3m +29.7%, 6m +21.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-054422, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 27, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -3,790 | $3.05 | $12k | 213,763 | May 29, 2025 |
| May 28, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -2,702 | $2.87 | $7,755 | 211,061 | May 29, 2025 |
| May 29, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -3,639 | $3.03 | $11k | 207,422 | May 29, 2025 |
| May 27, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -6,479 | $3.05 | $20k | 365,471 | May 29, 2025 |
| May 28, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -4,620 | $2.87 | $13k | 360,851 | May 29, 2025 |
| May 29, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -6,221 | $3.03 | $19k | 354,630 | May 29, 2025 |
| May 27, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -1,000 | $3.05 | $3,050 | 56,467 | May 29, 2025 |
| May 28, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -714 | $2.87 | $2,049 | 55,753 | May 29, 2025 |
| May 29, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -961 | $3.03 | $2,912 | 54,792 | May 29, 2025 |
| May 27, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -7,478 | $3.05 | $23k | 421,808 | May 29, 2025 |
| May 28, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -5,332 | $2.87 | $15k | 416,476 | May 29, 2025 |
| May 29, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -7,180 | $3.03 | $22k | 409,296 | May 29, 2025 |
| May 27, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -2,290 | $3.05 | $6,985 | 129,163 | May 29, 2025 |
| May 28, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -1,632 | $2.87 | $4,684 | 127,531 | May 29, 2025 |
| May 29, 2025 | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -2,199 | $3.03 | $6,663 | 125,332 | May 29, 2025 |
Related signals
Other insiders at Lantern Pharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 51Moderate | Lantern Pharma Inc. | D Jeffrey Keyser director | $100k 48,544 shares | +106% | |
| 49Moderate | Lantern Pharma Inc. | Lee Troy Schalop director | $100k 48,544 shares | - | |
| 42Moderate | Lantern Pharma Inc. | Aaron G.L. Fletcher owner | $208k 61,613 shares | -30% | |
| 35Weak | Lantern Pharma Inc. | Aaron G.L. Fletcher owner | $124k 40,000 shares | -20% | |
| 42Moderate | Lantern Pharma Inc. | Leslie W. Kreis owner | $208k 61,613 shares | -30% | |
| 35Weak | Lantern Pharma Inc. | Leslie W. Kreis owner | $124k 40,000 shares | -20% | |
| 41Moderate | Lantern Pharma Inc. | Leslie W. Kreis owner | $168k 56,237 shares | -26% | |
| 60Notable | Lantern Pharma Inc. | Aaron G.L. Fletcher owner | $676k 144,000 shares | -196% | |
| 60Notable | Lantern Pharma Inc. | Leslie W. Kreis owner | $676k 144,000 shares | -196% | |
| 53Moderate | Lantern Pharma Inc. | Aaron G.L. Fletcher owner | $247k 58,889 shares | -74% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.